Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Diabetes insipidus: a challenging diagnosis with new drug therapies.

Authors
  • Saifan, Chadi1
  • Nasr, Rabih1
  • Mehta, Suchita1
  • Sharma Acharya, Pranab1
  • Perrera, Isera1
  • Faddoul, Giovanni1
  • Nalluri, Nikhil1
  • Kesavan, Mayurakhan1
  • Azzi, Yorg1
  • El-Sayegh, Suzanne1
  • 1 Division of Nephrology, Department of Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA.
Type
Published Article
Journal
ISRN nephrology
Publication Date
Jan 01, 2013
Volume
2013
Pages
797620–797620
Identifiers
DOI: 10.5402/2013/797620
PMID: 24977135
Source
Medline
License
Unknown

Abstract

Diabetes Insipidus (DI) is either due to deficient secretion of arginine vasopressin (central) or to tubular unresponsiveness (nephrogenic). Drug induced DI is a well-known entity with an extensive list of medications. Polyuria is generally defined as urine output exceeding 3 liters per day in adults. It is crucial to identify the cause of diabetes insipidus and to implement therapy as early as possible to prevent the electrolyte disturbances and the associated mortality and morbidity. It is very rare to have an idiosyncratic effect after a short use of a medication, and physicians should be aware of such a complication to avoid volume depletion. The diagnosis of diabetes insipidus is very challenging because it relies on laboratory values, urine output, and the physical examination of the patient. A high clinical suspicion of diabetes insipidus should be enough to initiate treatment. The complications related to DI are mostly related to the electrolyte imbalance that can affect the normal physiology of different organ systems.

Report this publication

Statistics

Seen <100 times